Introducing the ML830
® LaserThe first laser to receive FDA clearance to market for the effective (non-surgical) treatment of Carpal Tunnel Syndrome.

CTS sufferers are now free to seek relief from hand and wrist pain through a new non-invasive form of therapy before resorting to surgery.

FDA market clearance for the ML830 Laser resulted from working with FDA examiners over the past ten years to ensure continuing compliance with the law.  The ML830 Laser successfully performed in double blind studies and in many clinical trials where some rather substantial parties were involved, including General Motors and Baylor College of Medicine


THE ML830 LASER: A NON-SURGICAL APPROACH TO RSI

In a rapidly developing technological workplace, our bodies simply cannot maintain the pace of high demand machines or repetitive motion. This daily effect of very fast, forceful and seemingly harmless movements of the shoulders, elbows, wrists and hands, from operating computers, to meat cutting, to assembling automobiles, to package handlers, adversely affects workers and industry worldwide. As the demands of productivity increase, so too do the physical demands placed on the individual. This leads to stressed muscles and tendons pushed far beyond their intended limits resulting in disorders commonly known as Repetitive Stress Injury or RSI. A very common RSI problem is Carpal Tunnel Syndrome or CTS. On industry world­wide, CTS has a major financial impact resulting in millions of lost dollars.

The ML830 Laser was designed by a team of doctors and leading medical engineers to harness the therapeutic application of advanced low energy laser technology.

Virtually all light has some penetration properties; however, it is often absorbed by the outermost skin layers. Traditional thermal (hot) laser light, on the other hand, can penetrate but often destroys tissue. As it is well known that damaged cells benefit from light, the objective was to develop a non-thermal and non-destructive deep tissue, delivery vehicle. The ML830 is a non-thermal laser capable of penetrating deep into tissue. Once delivered, the light energy promotes the process of photobiostimulation. The positive effect of photobiostimultion on animal cells is analogous to photosynthesis in plant cells whereby a chain of chemical reactions is set in motion. In human tissue the resulting photochemical reaction produces an increase in the cellular metabolism rate which expedites cell repair and the stimulation of the immune, lymphatic and vascular systems. The net result is the apparent reduction in pain, inflammation, edema and an overall reduction in healing time.

  Laser Type Gallium-Aluminum-Arsenide (GaAIA)
  Laser Wavelength 830 nm
  Regulatory Class III b
  Power 3-30 mW continuous wave (cw)
  Treatment Cycle Duration 33 Seconds per site treated
  Laser Energy delivered
per Treatment Cycle
3 x 1 Joule
  Standard Warranty 1 year parts and labor
  Service Options Extended warranty, on-site support, and training

CTS Info  |  ML830 Info  |  Research  |   Purchase/Lease  |  FAQ's  |  Find the ML830  |  Links
Contact Form  |  Press Releases  |  Privacy Statement  |  Copyright Info  |  Home

ML830® Copyright Info


All information & images ©2003-2004 Laser Therapeutic Technology, Inc.
Laser Therapeutic Technology, Inc., healing at the speed of light and each of their logos are trademarks of Laser Therapeutic Technology, Inc.
All rights reserved. All other trademarks appearing on this web site are the property of their respective owners.